Apply online
Complete a confidential eligibility questionnaire (5–10 minutes).
Now recruiting in Perth
Researchers at Clinical Research Australia are investigating whether a probiotic supplement can improve quality of life during perimenopause.
You may be eligible if you are aged 40–55, have experienced changes in your menstrual cycle, and have ongoing perimenopausal symptoms affecting your quality of life.
Online questionnaire takes 5–10 minutes · Confidential · No obligationPerimenopause can feel different for everyone
You do not need to experience all these symptoms to apply.
About the research
Preliminary research suggests probiotics may help with symptoms experienced during the menopausal transition. This study will investigate whether a probiotic called LactoSpore® can improve menopause-related quality of life, including mood, sleep, energy, concentration, vasomotor symptoms, libido, digestion, joint comfort and overall wellbeing.
Blood markers that may be associated with perimenopausal symptoms will also be measured. This is an ethics-approved, randomised, double-blind, placebo-controlled clinical trial. Half of participants will receive LactoSpore® and half will receive placebo capsules.
What participation involves
Complete a confidential eligibility questionnaire (5–10 minutes).
A researcher will discuss the study and assess your eligibility (about 10 minutes).
Attend two assessment visits—at baseline and week 12 (about 30 minutes each).
Samples are collected at a Western Diagnostics Pathology clinic at baseline and week 12.
Take one probiotic or placebo capsule daily for 12 weeks.
Complete brief questionnaires online at weeks 4 and 8 (about 10 minutes).
Who may be suitable?
Take the first step
Complete the short, confidential questionnaire to help our research team assess your eligibility. Applying does not commit you to taking part.
Questions? Call our research team on 08 9448 7376Future study opportunities
Join our participant community and receive occasional emails when new clinical trials begin recruiting.